Trial intelligence / Profile preview

NAC for Comorbid PTSD and Substance Abuse

NCT02499029Phase 2Completed

Sponsor
Medical University of South Carolina
Start
Feb 2013
Primary completion
Sep 2014
Modality
Small Molecules
01

Overview

A Phase 2 trial of acetylcysteine in post-traumatic stress disorder (PTSD), substance-related disorders, sponsored by Medical University of South Carolina. Started Feb 2013; status: completed.

02

Drugs

acetylcysteine
03

Conditions

post-traumatic stress disorder (PTSD)substance-related disorders

Beyond the preview

Go deeper on NCT02499029.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02499029.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call